Form 8-K - Current report:
SEC Accession No. 0001171843-19-005142
Filing Date
2019-08-05
Accepted
2019-08-05 11:32:21
Documents
2
Period of Report
2019-08-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_080519.htm 8-K 10831
2 PRESS RELEASE exh_991.htm EX-99.1 70047
  Complete submission text file 0001171843-19-005142.txt   82158
Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
Arbutus Biopharma Corp (Filer) CIK: 0001447028 (see all company filings)

EIN.: 980597776 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34949 | Film No.: 19997934
SIC: 2834 Pharmaceutical Preparations